semaglutide risk of cancer Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study - Baser - 2024 - Obesity Science & Practice

Is Ozempic (Semaglutide) Lower the Risk of Dementia?

20.42

★★★★☆4.8 (126)

Could GLP-1 medications play a role in reducing breast cancer recurrence risk? In a story for Oprah Daily, Melinda Irwin, PhD, MPH, explains that weight management can improve inflammation, metabolism, immune function,

22.69

★★★★★4.9 (98)

Weight-Loss Drugs May Have Surprising Side Effect: Stalling Cancer

24.38

★★★★★5.0 (157)

For years, researchers have known that obesity is associated with an increased risk of developing and dying from several cancers, including breast cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists

22.33

★★★★★4.7 (84)

Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review

21.13

★★★★★4.9 (203)

Recent study finds that semaglutide medication may benefit 93 million U.S. adults

24.73

★★★★★5.0 (176)

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

22.35

★★★★★4.8 (132)